ProgramName X Strategic Growth 2026 → 2028
Live · Q3 2026
Filters

Executive Overview

12 strategic priorities in scope · single source of truth

Target Revenue

€6.07B

Baseline €3.89B

Revenue Attainment

78%

Actual €4.75B

Portfolio CAGR

10.2%

Weighted across active priorities

Investment

€566M

86% of €656M planned

Revenue Trajectory

Baseline → Target · 2024 – 2028

Portfolio Health

On Track6
At Risk3
Delayed2
Completed1

Top strategic priorities

Sorted by commercial impact

EV Software Platform

Automotive · Germany · Daniel Roth

72%
€192M
On Track

Grid Flexibility Services

Energy & Utilities · USA · James O'Neill

66%
€148M
On Track

Smart Factory Rollout

Industrial Manufacturing · Spain · Marc Dubois

22%
€128M
Delayed

Oncology Real-World Evidence

Healthcare & Pharma · Germany · Ravi Menon

41%
€118M
At Risk

D2C Marketplace Launch

Consumer Goods · Italy · Chiara Bianchi

34%
€105M
At Risk

Key Account Growth EMEA

Industrial Manufacturing · Germany · Chiara Bianchi

64%
€104M
On Track

AI Summary

5 of 12 priorities need attention. Investment is tracking at 86% of plan. Two opportunities identified for near-term acceleration.

risk · 82% conf.

Smart Factory Rollout trending 6 weeks behind plan

risk · 76% conf.

Distributed Renewables Ops at risk of missing 2027 target

opportunity · 71% conf.

Grid Flexibility Services outperforming — expand to Spain